Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Statistical analysis of dose-volume profiles and its implication for radiation therapy planning in prostate carcinoma.

Vanasek J, Odrazka K, Dolezel M, Kolarova I, Jarkovsky J, Pavlik T, Hlavka A, Dusek L.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):769-76. doi: 10.1016/j.ijrobp.2013.03.018. Epub 2013 Apr 26.

PMID:
23628133
2.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
3.

[Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer].

Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.

Cancer Radiother. 2004 Apr;8(2):59-69. English, French.

PMID:
15063872
4.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
5.

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):932-8. doi: 10.1016/j.ijrobp.2013.07.041. Epub 2013 Oct 8.

6.
7.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402.

PMID:
10661346
8.

Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.

Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M.

Radiat Oncol. 2006 Sep 6;1:34.

9.

Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.

Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):235-41. doi: 10.1016/j.ijrobp.2010.09.058. Epub 2010 Dec 14.

PMID:
21163587
10.

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity.

Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, Rosen II.

Int J Radiat Oncol Biol Phys. 1996 Feb 1;34(3):555-64.

PMID:
8621278
11.

Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.

Smeenk RJ, van Lin EN, van Kollenburg P, Kunze-Busch M, Kaanders JH.

Radiother Oncol. 2009 Oct;93(1):131-6. doi: 10.1016/j.radonc.2009.05.014. Epub 2009 Jun 10.

PMID:
19523704
12.

Short-course, intensity-modulated radiotherapy for localized prostate cancer.

Kupelian PA, Willoughby TR.

Cancer J. 2001 Sep-Oct;7(5):421-6.

PMID:
11693901
13.

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):192-8.

PMID:
12694838
14.

Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.

Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9.

PMID:
16111582
15.

Role of IMRT in reducing penile doses in dose escalation for prostate cancer.

Sethi A, Mohideen N, Leybovich L, Mulhall J.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):970-8.

PMID:
12605975
16.

A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.

Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):400-8.

PMID:
15667959
17.

Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.

Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.

Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.

PMID:
18215434
18.

Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.

Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1142-52. Epub 2005 Jun 4.

PMID:
15939547
19.

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

Jackson A, Skwarchuk MW, Zelefsky MJ, Cowen DM, Venkatraman ES, Levegrun S, Burman CM, Kutcher GJ, Fuks Z, Liebel SA, Ling CC.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):685-98.

PMID:
11172950
20.

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9. doi: 10.1016/j.ijrobp.2007.11.044.

PMID:
18313526

Supplemental Content

Support Center